Growth hormone reduces abdominal fat, cardiovascular risk factors in HIV patients on antiviral therapy

Thursday, July 31, 2008 - 11:21 in Health & Medicine

Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection. However, growth hormone treatment appeared to increase blood glucose levels, particularly in those already exhibiting glucose intolerance.  The study from researchers at Harvard Medical School and Massachusetts General Hospital (MGH) appears in the Aug. 6 Journal of the American Medical Association, a special issue on HIV/ more

Read the whole article on Harvard Science

More from Harvard Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net